Furosemide Injection, Solution
Product Images NDC 51662-1336

9 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 51662-1336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Furosemide showing its molecular arrangement with a benzene ring, sulfonamide, carboxylic acid, chlorine, and a furan group. The diagram is a black-and-white line drawing illustrating the chemical bonds and substituents.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
A data table listing unit of sale and concentration information for various FUROSEMIDE injection solutions, including NDC numbers, carton sizes (e.g., containing 25 vials), and bundle sizes (e.g., containing 10 ANSYR syringes), with concentrations noted as 10 mg/mL and corresponding total dosages per vial or syringe volumes.*
FDA Label Image

Logo (Logo How Supplied)

FDA Label Image

Vial (Vial Label)

Vial (Vial Label)
Furosemide Injection, USP 10 mg/mL (40 mg/4 mL) single-use vial label. The label indicates it is for intravenous or intramuscular use and includes handling instructions such as avoiding use if the solution is discolored or contains particulates. The label features the Hospira, Inc. logo and details, along with barcodes and lot/expiration information.*
FDA Label Image

Serialized Labeling (1336 1 Serialized Labeling)

Serialized Labeling (1336 1 Serialized Labeling)
Furosemide Injection USP 10 mg/mL, 4 mL single-use vial for intramuscular or intravenous use. The amber glass vial has an orange cap and a label showing the product name, strength, dosage form, and use instructions. Distributed by HF Acquisition Co LLC.*
FDA Label Image

Pouch Label (51662 1336 2)

Pouch Label (51662 1336 2)
FUROSEMIDE injection, solution 10 mg/mL in a 4 mL vial. The label displays product NDC 51662-1336-2 and includes lot number and expiration date. It contains warnings for intravenous or intramuscular use, dosage limits, and storage instructions. Distributed by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*
FDA Label Image

Case Label (51662 1336 3)

Case Label (51662 1336 3)
Packaging label for FUROSEMIDE Injection, USP 40 mg/4 mL (10 mg/mL) in a 4 mL vial, presented as a box of 25 by HF Acquisition Co LLC, DBA HealthFirst. The label includes NDC 51662-1336-3, lot and expiration date information, and usage instructions for intravenous or intramuscular administration. It specifies storage conditions and a caution to discard unused portions.*
FDA Label Image

Rfid Label (51662 1336 3 Rfid Case)

Rfid Label (51662 1336 3 Rfid Case)
Label of FUROSEMIDE 10 mg/mL injection, solution for intramuscular and intravenous use. The label indicates distribution by HF Acquisitions Co LLC, DBA HealthFirst, Mukilteo, WA. The label includes a barcode and various serialized numbers along with instructions to see the manufacturer's insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.